Patents by Inventor Jonathan Hutton

Jonathan Hutton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eyewear providing anatomically stabilized control of an associated electronic device
    Patent number: 9535267
    Abstract: Control of an electronic device integrated with eyewear is facilitated by the use of anatomical reference points. Palpable alignment features, such as protrusions, notches etc. on the eyewear are aligned with anatomic reference points to put a user's fingers into a desired spatial relationship with a control for the device.
    Type: Grant
    Filed: March 15, 2015
    Date of Patent: January 3, 2017
    Inventors: Jonathan Hutton Trigg, Antony Frederic Trigg, Steven Michel Trigg
  • Eyewear Providing Anatomically Stabilized Control of an Associated Electronic Device
    Publication number: 20160266413
    Abstract: Control of an electronic device integrated with eyewear is facilitated by the use of anatomical reference points. Palpable alignment features, such as protrusions, notches etc. on the eyewear are aligned with anatomic reference points to put a user's fingers into a desired spatial relationship with a control for the device.
    Type: Application
    Filed: March 15, 2015
    Publication date: September 15, 2016
    Inventors: Jonathan Hutton Trigg, Antony Frederic Trigg, Steven Michel Trigg
  • Crystalline 1-alkyl-2-quinolinium salts
    Patent number: 5446165
    Abstract: The invention concerns quinolinium salt intermediates of the formula I ##STR1## and processes for their manufacture; and their use in the manufacture of aryloxymethyl-substituted 1-alkyl-2-quinolone derivatives which are 5-lipoxygenase inhibitors.
    Type: Grant
    Filed: August 17, 1993
    Date of Patent: August 29, 1995
    Assignees: Zeneca Limited, Zeneca Pharma
    Inventors: Jonathan Hutton, David Waterson
  • Chemical process
    Patent number: 5326869
    Abstract: A process for the preparation of a 5,7-diaryloxy-2-(2-heteroaryl)-triazolo[1,5-a][1,3,5]triazine, which comprises reacting a N-2-(4,6-diaryloxy)-[1,3,5]triazinyl-N'-(2-heteroarylcarbonyl)hydrazine with a polyphosphoric acid silyl ester. The invention also provides a multistep process for preparing certain triazolotriazines having activity asadenosine antagonists.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: July 5, 1994
    Assignee: Imperial Chemical Industries, PLC
    Inventor: Jonathan Hutton
  • Process for the manufacture of crystalline quinolinium salts and their oxidation to 1-alkyl-2-quinolones
    Patent number: 5260442
    Abstract: The invention concerns quinolinium salt intermediates of the formula I ##STR1## and processes for their manufacture; and their use in the manufacture of aryloxymethyl-substituted 1-alkyl-2-quinolone derivatives which are 5-lipoxygenase inhibitors.
    Type: Grant
    Filed: December 5, 1991
    Date of Patent: November 9, 1993
    Assignees: Imperial Chemical Industries PLC, ICI Pharma
    Inventors: Jonathan Hutton, David Waterson
  • Process for the manufacture of p-hydroxybenzyl cyanide
    Patent number: 4317781
    Abstract: An improved process for the preparation of p-hydroxybenzyl cyanide by the reaction of p-hydroxybenzyl alcohol with an alkali metal cyanide, by carrying out the process in the presence of an alkyl formate, especially n-propyl formate. The cyanide product is a valuable intermediate for the preparation of the .beta.-adrenergic blocking agent atenolol.
    Type: Grant
    Filed: April 13, 1981
    Date of Patent: March 2, 1982
    Assignee: Imperial Chemical Industries Limited
    Inventor: Jonathan Hutton